Targeting RET Solvent-Front Mutants with Alkynyl Nicotinamide-Based InhibitorsUjjwol Khatri, Jie Wu|Molecular Cancer Therapeutics|2023Cited by 14
Identification of alkynyl nicotinamide HSN748 as a RET solvent-front mutant inhibitor with intracranial efficacyUjjwol Khatri, Jie Wu|RSC Medicinal Chemistry|2025Cited by 1